Akoya BioSciences Shares Are Trading Higher After the Company Announced That the Company's PhenoCycler Fusion and PhenoImager HT Spatial Proteomics Platforms Will Be Used to Analyze Tissue Samples as Part of the MANIFEST Program.
Akoya BioSciences Shares Are Trading Higher After the Company Announced That the Company's PhenoCycler Fusion and PhenoImager HT Spatial Proteomics Platforms Will Be Used to Analyze Tissue Samples as Part of the MANIFEST Program.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated